Tatva Chintan Pharma is a specialized chemical making company located in VadodaraTatva Chintan Pharma's Rs 500 crore going public (IPO) opens for subscription today.
The IPO will include fresh concern of shares worth Rs 225 crore and a deal of sale totaling up to Rs 225 crore by existing promoters and shareholders.
The issue will remain open for three days till July 20, 2021 and the shares will be offered in the cost band of Rs 1,073-1,083 per share.
The shares are likely to be noted on the bourses.Tatva Chintan Pharma's IPO will be the 4th specialty chemical business go public in 2021 after Anupam Rasayan India, Clean Science - & Innovation and Laxmi Organic Industries.Investors can look for a minimum one lot of 13 shares and in multiples thereof, extending upto 14 lots.Tatva Chintan will make use of the IPO proceeds to money its capital expenditure requirements, broaden its Dahej manufacturing center and upgrade the R&D facility in Vadodara, and for general business purposes.Tatva Chintan Pharma, promoted by Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah and Snehkar Rasiklal Somani, is a specialized chemical making company situated in Vadodara.
It exports products to more than 25 nations, consisting of the United States, China, Germany, Japan, South Africa and United Kingdom.ICICI Securities and JM Financial are the book running lead managers to the concern, whereas Link Intime India is the registrar to the concern.